U.S. markets closed
  • S&P 500

    3,271.03
    -119.65 (-3.53%)
     
  • Dow 30

    26,519.95
    -943.24 (-3.43%)
     
  • Nasdaq

    11,004.87
    -426.48 (-3.73%)
     
  • Russell 2000

    1,543.28
    -47.21 (-2.97%)
     
  • Crude Oil

    37.63
    +0.24 (+0.64%)
     
  • Gold

    1,877.80
    -1.40 (-0.07%)
     
  • Silver

    23.43
    +0.08 (+0.33%)
     
  • EUR/USD

    1.1751
    -0.0039 (-0.33%)
     
  • 10-Yr Bond

    0.7810
    +0.0030 (+0.39%)
     
  • GBP/USD

    1.2985
    -0.0056 (-0.43%)
     
  • USD/JPY

    104.3060
    -0.1880 (-0.18%)
     
  • BTC-USD

    13,291.92
    +91.03 (+0.69%)
     
  • CMC Crypto 200

    261.22
    -11.47 (-4.20%)
     
  • FTSE 100

    5,582.80
    -146.19 (-2.55%)
     
  • Nikkei 225

    23,418.51
    -67.29 (-0.29%)
     

Illumina to Webcast Upcoming Investor Conference Presentation

·1 min read

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast.

Cowen’s Liquid Biopsy Summit
Thursday, September 24, 2020 at 9:30am Pacific Time

The live webcasts can be accessed in the Investor Info section of Illumina's web site under the "company" tab at www.illumina.com. A replay of the presentations will be posted on Illumina’s website after the event and will be available for at least 30 days following.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram and YouTube.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200923005895/en/

Contacts

Investors:
Jacquie Ross, CFA
+1.858.882.2172
ir@illumina.com

Media:
Dr. Karen Birmingham
+44.7500.105665
kbirmingham@illumina.com